Retina Gallery ~ Full Sized Retina Images

Myopic CNVM - lacquer crack - recurrence 6 years later 31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 25931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 24731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19831 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21731 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 24231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 26031 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 25131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 25331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 19131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20531 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21331 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 20231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21631 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 25231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 22431 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 21931 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 26231 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvaatamisi: 23131 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 hinnangut)
40 faili 1 lehel

31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.